PFE has a similar compound, but I don’t know that program’s status.
If you're thinking of the pan caspase inhibitor PFE acquired from Idun, I have not seen it progressing in trials for treatment of NASH (I think it did not progress in the other indications either).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.